The scaffold can be loaded with tumor antigens, toll-like receptor (TLR) agonists, adjuvants, GM-CSF, metabolic inhibitors (indoleamine 2,3-dioxygenase 1, IDO1 inhibitor), and various chemoattractants to recruit and activate multiple DC subsets for a prolonged period. The gene discussed is CSF2; the disease is neoplasm.